QuidelOrtho Corp. Hits Day Low at $17.03 Amid Price Pressure

QuidelOrtho Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility today, with the stock dropping by 10.93%. The stock reached an intraday low of USD 17.03, reflecting ongoing challenges for the company. Over the past month, QuidelOrtho has seen a steep decline of 29.51%, and its year-to-date performance stands at a loss of 40.37%. The company's struggles are evident in its long-term performance metrics, with a staggering 51.19% drop over the past year and an alarming 79.97% decline over the last three years. Financial indicators reveal a concerning picture, with a debt-equity ratio of 138.72% and a low interest coverage ratio of 142.31. The company's return on equity is negative at -7.95%, and it has not paid dividends, reflecting its current financial difficulties. QuidelOrtho's performance has consistently lagged behind the S&P 500, highlighting its ongoing challenges in the competitive market landscape.